Drug Trial Radar · NCT05096208
Clinical Lot Consistency for RSVpreF in a Population of Healthy Adults 18 to ≤49 Years of Age
Last checked: Nov 19, 2026Latest source record: Apr 12, 2023 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
1,028
Actual
Start
Oct 21, 2021
Primary completion
Apr 4, 2022
Study completion Apr 4, 2022
Sponsor
- Lead sponsor
- PfizerPfizer (PFE)
- Sponsor type
- Industry
- First posted
- Oct 27, 2021
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Prevention
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 49 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
This randomized, double-blinded, placebo-controlled Phase 3 study is designed to evaluate the safety, tolerability, and immunogenicity of 3 lots of RSVpreF in healthy adults.
Conditions
- RSV
Interventions
RSVpreF (Group 1)Biological
RSV vaccine (RSVpreF)
RSVpreF (Group 2)Biological
RSV vaccine (RSVpreF)
RSVpreF (Group 3)Biological
RSV vaccine (RSVpreF)
PlaceboBiological
Placebo
Primary outcomes
What the sponsor says the trial is designed to measure.
- Geometric Mean Ratios (GMRs) of Respiratory Syncytial Virus Subgroup A (RSV A) and B (RSV B) Neutralizing Antibodies at 1 Month After Vaccination for Every Pair of RSVpreF LotsTime frame: 1 month (27 to 42 days window) after vaccination on Day 1
- Percentage of Participants With Local Reactions Within 7 Days After VaccinationTime frame: Within 7 days after vaccination on Day 1
- Percentage of Participants With Systemic Events Within 7 Days After VaccinationTime frame: Within 7 days after vaccination on Day 1
- Percentage of Participants With Adverse Events (AEs) and Serious Adverse Events (SAEs)Time frame: Day of consent (Day 1) through study completion (approximately 1 Month)
Locations
18 sites in 1 country. Site status is shown where the registry gives one.
Global Health Research Center, Inc.
Miami Lakes, Florida
Precision Clinical Research
Sunrise, Florida
Clinical Site Partners, Inc
Winter Park, Florida
Clinical Site Partners
Winter Park, Florida
Clinical Research Atlanta
Stockbridge, Georgia
East-West Medical Research Institute
Honolulu, Hawaii
Clinical Research Prime
Idaho Falls, Idaho
Kentucky Pediatric/ Adult Research
Bardstown, Kentucky
Sundance Clinical Research
St Louis, Missouri
Meridian Clinical Research, LLC
Omaha, Nebraska
Accellacare - Wilmington
Wilmington, North Carolina
Aventiv Research Inc
Columbus, Ohio
Velocity Clinical Research, Providence
East Greenwich, Rhode Island
Benchmark Research
Austin, Texas
Texas Center for Drug Development, Inc.
Houston, Texas
DM Clinical Research
Tomball, Texas
J. Lewis Research, Inc. / Foothill Family Clinic
Salt Lake City, Utah
J. Lewis Research, Inc. / Foothill Family Clinic South
Salt Lake City, Utah
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.